Medicine and Dentistry
Infective Endocarditis
100%
Infection
58%
Endocarditis
57%
Prospective Cohort Study
38%
Antibiotics
36%
Cost-Effectiveness Analysis
33%
Hepatitis C
32%
Antibiotic Resistance
28%
Staphylococcus Aureus
26%
Antiviral Drug
26%
Sepsis
22%
Diseases
21%
Pathogen
20%
Hepatitis C Treatment
19%
Microbiome
17%
Antibiotic Prophylaxis
16%
Adolescence
16%
Meningococcal Disease
16%
Human immunodeficiency virus
16%
Infectious Disease
16%
Apoplexy
15%
Hepatitis C Virus
15%
Mortality Rate
14%
Hazard Ratio
14%
Tertiary Care
13%
Heart Surgery
13%
Valve Replacement
13%
Heart Valve Prosthesis
12%
Surgical Infection
12%
Hospital Mortality
11%
Influenza A
10%
Cohort Effect
10%
Antibiotic Therapy
10%
Quality of Life
10%
Recombinant
10%
Immunocompromised Patient
10%
Virus
10%
Antiinfective Agent
9%
Antifungal Therapy
9%
Clinician
9%
Patient Referral
9%
Hemodialysis
8%
Prosthetic Valve Endocarditis
8%
Health Care Cost
8%
Surgery
8%
Odds Ratio
8%
Dengue Virus
8%
Physician
8%
Dermis
8%
Liver Abscess
8%
Immunology and Microbiology
Staphylococcus aureus
37%
Salmonella enterica
24%
Microflora
23%
Microbiome
19%
Methicillin-Resistant Staphylococcus Aureus
18%
Influenza
16%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Urinary Tract
16%
Bacteriophage
16%
Minimum Inhibitory Concentration
16%
Influenza A Virus (H1N1)
16%
Influenza Vaccine
16%
Endocarditis
16%
Proteomics
16%
Alternative Complement Pathway
16%
Factor H
13%
Etest
13%
Receptor Binding
12%
Enterobacteriaceae
12%
Immune Response
12%
Immunoglobulin Variable Region
11%
Bacterial Viability
10%
COVID-19
10%
Immunogenicity
10%
Hemagglutinin
10%
Infectious Agent
9%
Antimicrobial Resistance
9%
Pseudomonas aeruginosa
9%
Intestine Flora
9%
Vaccine Adjuvant
9%
Coinfection
9%
Antibody Blood Level
9%
Antibody
9%
Microbiology
8%
Viral Disease
8%
Adjuvant
8%
Complement Factor B
8%
Lineages
8%
HBsAg
8%
Trophozoite
8%
Acanthamoeba castellanii
8%
Foot
8%
Salmonella
8%
Septic Arthritis
8%
Cladistics
8%
Antitoxin
8%
Airway
8%
Hepatitis B Antigen
8%
Whole Genome Sequencing
8%
Staphylococcus Lugdunensis
8%
Pharmacology, Toxicology and Pharmaceutical Science
Vancomycin
53%
Bacterial Endocarditis
32%
Endocarditis
26%
Prospective Cohort Study
24%
Staphylococcus aureus
21%
Infection
20%
Live Attenuated Influenza Vaccine
16%
Influenza A Virus (H3N2)
12%
Daptomycin
12%
Antibiotics
11%
Antiinfective Agent
9%
Aminoglycoside
9%
Colistimethate
9%
Quinolone Derivative
9%
Malignant Neoplasm
8%
Bacteriophage
8%
Cyclorphan
8%
Wound Infection
8%
Dalbavancin
8%
Solithromycin
8%
Hepatitis C Virus
8%
Hepatitis C
8%
Hepatitis B Antigen
8%
Candida
8%
Voriconazole
8%
Antibiotic Therapy
8%
Staphylococcal Pneumonia
8%
Influenza A
8%
Encephalitis
8%
Adjuvant
8%
Infectious Agent
8%
Peginterferon
8%
Ribavirin
8%
Monarthritis
8%
Bacterial Arthritis
8%
Immunogenicity
8%
Clavulanic Acid
8%
Amoxicillin
8%
Vascular Disease
8%
Inflammation
8%
Thioester
8%
Sepsis
8%
Mycoplasma hominis
8%
Inulin
8%
Low Density Lipoprotein Cholesterol
8%
Panton-Valentine Leukocidin
8%
Statin (Protein)
8%
Polymyxin
6%
Ciprofloxacin
6%
Ofloxacin
6%